LY2109761: Mechanism of Action

LY2109761 MOA:Targeting TGF-β Receptor/TGF-β/SMAD Signaling Pathway for Oncology and Cancer Metastasis Research

🎯 check LY2109761 product page

LY2109761 is a potent dual TGF-β receptor I/II inhibitor. It affects the TGF-β/Smad signaling pathway by blocking Smad2/3 phosphorylation, effectively inhibiting epithelial-mesenchymal transition, fibrosis, and tumor progression.

Primary Applications and Mechanism of Action